Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01660035 · ClinicalTrials.gov registry record

The Product Surveillance Registry REVERSE Post Approval Study

A clinical trial, sponsored by Medtronic.

Completed
Registry status
155
Enrollment target

NCT01660035 is a clinical trial that has completed, run by Medtronic. The registered enrollment target is 155 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01660035 has completed, sponsored by Medtronic.

COMPLETED
Registry status
155 participants
Enrollment target

Study Summary

The purpose of the REVERSE Post Approval Study (PAS) is to confirm the benefit observed in the REVERSE and RAFT pivotal studies in "real-world" clinical practice.

Trial Details

FieldValue
Enrollment Target 155 participants
Start Date 2012-04
Est. Completion 2022-04

Sponsor

Medtronic

30 total trials

What the Registry Record Tells You About NCT01660035

The ClinicalTrials.gov registry entry for NCT01660035 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 155 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medtronic, which has 30 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT01660035 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01660035 about?

NCT01660035 is a clinical study titled "The Product Surveillance Registry REVERSE Post Approval Study". The purpose of the REVERSE Post Approval Study (PAS) is to confirm the benefit observed in the REVERSE and RAFT pivotal studies in "real-world" clinical practice.

What is the current status of trial NCT01660035?

This trial is currently completed. The enrollment target is 155 participants. The study started on 2012-04. Estimated completion is 2022-04.

Who is sponsoring clinical trial NCT01660035?

This trial is sponsored by Medtronic, which has 30 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.